101185871_3yiyp23zk51ggkzl4pzgt345

S41 - LPL-NEW FRIENDS

COLONY

D-819,GROUND FLOOR,NEAR

ESCORTS HOSPITAL ,NEW

FRIENDS COLONY

Name

A/c Status

Lab No.

Ref By :

Gender: Age:

Report Status

Reported

Received

Collected

P

21/8/2013 11:23:26AM

:

:

:

:

:

:

: Interim

40 Years

20/8/2013 1:46:00PM

20/8/2013 1:50:10PM101185871 Male

DR. S.L. BROOR, MNAMS

Mr. PANKAJ

Test Name Results Units Ref. Range

LIVER PANEL 1; LFT,SERUM

(Spectrophotometry)

98.00AST (SGOT) <50.00 U/L

171.00ALT (SGPT) <50.00 U/L

452.00GGTP <55.00 U/L

250.00Alkaline Phosphatase (ALP) 30.00 - 120.00 U/L

2.77Bilirubin Total 0.30 - 1.20 mg/dL

1.46Bilirubin Direct <0.20 mg/dL

1.31Bilirubin Indirect <1.10 mg/dL

7.90Total Protein 6.40 - 8.30 g/dL

4.20Albumin 3.50 - 5.20 g/dL

1.14A : G Ratio 0.90 - 2.00

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 3)

.

Page 1 of 5


COLONY



FRIENDS COLONY

Name

A/c Status

Lab No.

Ref By :

Gender:Age:

Report Status

Reported

Received

Collected

P

21/8/2013 11:23:28AM

:

:

:

:

:

:

: Interim

40 Years

20/8/2013 1:46:00PM

20/8/2013 1:50:10PM101185871 Male


Mr. PANKAJ


PROTHROMBIN TIME STUDIES

(Electromechanical Clot Detection)

Mean Normal Prothrombin Time (PT) 13.20 sec

Patient value 13.20 sec 11.88 - 14.61

Prothrombin Ratio (PR) 1.00

International Normalized Ratio (INR) 1.00 0.90 - 1.10

Note

1. INR is the parameter of choice in monitoring adequacy of oral anticoagulant therapy. Appropriate

therapeutic range varies with the disease and treatment intensity

2. Prolonged INR suggests potential bleeding disorder / bleeding complications

3. Results should be clinically correlated

4. Test conducted on Citrated plasma

Recommended Therapeutic range for Oral Anticoagulant therapy

INR 2.0-3.0 :

· Treatment of Venous thrombosis & Pulmonary embolism

· Prophylaxis of Venous thrombosis (High risk surgery)

· Prevention of systemic embolism in tissue heart valves, AMI, Valvular heart disease &

Atrial fibrillation

· Bileaflet mechanical valve in aortic position

INR 2.5-3.5:

§ Mechanical prosthetic valves

§ Systemic recurrent emboli

Comments

Prothrombin time measures the extrinsic coagulation pathway which consists of activated Factor VII (VIIa),

Tissue factor and Proteins of the common pathway (Factors X, V, II & Fibrinogen). This assay is used to

control long term oral anticoagulant therapy, evaluation of liver function & to evaluate coagulation disorders

specially factors involved in the extrinsic pathway like Factors V, VII, X, Prothrombin & Fibrinogen.

HEPATITIS B SURFACE ANTIGEN;HBsAg, SERUM

(CMIA)

0.02 IU/mL <0.05

Interpretation

-------------------------------------------| RESULT IN IU/mL | REMARKS ||-----------------|-------------------------|| <0.05 | Non Reactive ||-----------------|-------------------------|| >=0.05 | Reactive | -------------------------------------------

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 3)

.

Page 2 of 5


COLONY



FRIENDS COLONY

Name

A/c Status

Lab No.

Ref By :

Gender:Age:

Report Status

Reported

Received

Collected

P

21/8/2013 11:23:28AM

:

:

:

:

:

:

: Interim

40 Years

20/8/2013 1:46:00PM

20/8/2013 1:50:10PM101185871 Male


Mr. PANKAJ


Note

1. Reactive results suggest Acute / Chronic infection / Carrier state

2. Discrepant results may be observed during pregnancy, patients receiving mouse

monoclonal antibodies for diagnosis or therapy & mutant forms of HBsAg

3. For diagnostic purposes, results should be used in conjunction with clinical history

and other hepatitis markers for diagnosis of Acute or Chronic infection

4. For heparinized patients, draw specimen prior to heparin therapy as presence of fibrin leads to

erroneous results

Comments

Hepatitis B Virus (HBV) is a member of the Hepadna virus family causing infections of the liver with

extremely variable clinical features. Hepatitis B is transmitted primarily by body fluids especially serum

and also spread effectively sexually and from mother to baby. In most individuals HBV hepatitis is self

limiting, but 1-2% normal adolescents and adults develop Chronic Hepatitis. Frequency of chronic

HBV infection is 5-10% in immunocompromised patients and 80% in neonates. The initial serological

marker of acute infection is HBsAg which typically appears 2-3 months after infection and disappears

12-20 weeks after onset of symptoms. Persistence of HBsAg for more than six months indicates

development of carrier state or Chronic liver disease.

Uses

· Routine screening of blood and blood products to prevent transmission of Hepatitis B virus (HBV) to

recipients

· To diagnose suspected HBV infection and monitor the status of infected individuals

· To evaluate the efficacy of antiviral drugs

· For Prenatal Screening of pregnant women

Advised : All Reactive results should be confirmed by Neutralization test ( HBsAg confirmatory test)

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 3)

.

Page 3 of 5


COLONY



FRIENDS COLONY

Name

A/c Status

Lab No.

Ref By :

Gender: Age:

Report Status

Reported

Received

Collected

P

21/8/2013 11:23:30AM

:

:

:

:

:

:

: Interim

40 Years

20/8/2013 1:46:00PM

20/8/2013 1:50:10PM101185871 Male


Mr. PANKAJ


COMPLETE BLOOD COUNT (CBC)

(Electrical Impedance & VCS)

Hemoglobin 13.00 - 17.00 g/dL13.70

Packed Cell Volume (PCV) 40.00 - 50.00 %43.70

RBC Count 4.50 - 5.50 mill/mm34.47

MCV 80.00 - 100.00 fL97.70

MCH 27.00 - 32.00 pg30.70

MCHC 32.00 - 35.00 g/dL31.40

Red Cell Distribution Width (RDW) 11.50 - 14.50 %15.10

Total Leukocyte Count (TLC) 4.00 - 10.00 thou/mm35.30

Differential Leucocyte Count (DLC)

40.00 - 80.00 Segmented Neutrophils %54.40

20.00 - 40.00 Lymphocytes %30.80

2.00 - 10.00 Monocytes %11.80

1.00 - 6.00 Eosinophils %1.80

<2.00 Basophils %1.20

Absolute Leucocyte Count

2.00 - 7.00 Neutrophils thou/mm32.90

1.00 - 3.00 Lymphocytes thou/mm31.60

0.20 - 1.00 Monocytes thou/mm30.60

0.02 - 0.50 Eosinophils thou/mm30.10

0.01 - 0.10 Basophils thou/mm30.10

Platelet Count 150.00 - 450.00 thou/mm3176.0

Note

1. As per the recommendation of International council for Standardization in Hematology, the differential

leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of

blood

2. Test conducted on EDTA whole blood

PatientReportSCSuperPanel.CBC_SC (Version: 3)

.

Page 4 of 5


COLONY



FRIENDS COLONY

Name

A/c Status

Lab No.

Ref By :

Gender: Age:

Report Status

Reported

Received

Collected

P

21/8/2013 11:23:30AM

:

:

:

:

:

:

: Interim

40 Years

20/8/2013 1:46:00PM

20/8/2013 1:50:10PM101185871 Male


Mr. PANKAJ


Dr. Ankur Malik

MD (Pathology)

Consultant Pathologist

Dr Onjal Taywade

MD (Biochemistry)

Consultant Biochemist

Dr. Sushrut Pownikar

DNB (Pathology)

HOD Hemat & Imm

HEPATITIS E ANTIBODY (HEV), IgM, SERUM

Result/s to follow:

PatientReportSCSuperPanel.CBC_SC (Version: 3)

.

Page 5 of 5

Documents

101185871_3yiyp23zk51ggkzl4pzgt345